Brian F. Gage

25.3k total citations · 10 hit papers
180 papers, 17.4k citations indexed

About

Brian F. Gage is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pharmacology. According to data from OpenAlex, Brian F. Gage has authored 180 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Cardiology and Cardiovascular Medicine, 43 papers in Internal Medicine and 37 papers in Pharmacology. Recurrent topics in Brian F. Gage's work include Atrial Fibrillation Management and Outcomes (44 papers), Venous Thromboembolism Diagnosis and Management (43 papers) and Pharmacogenetics and Drug Metabolism (36 papers). Brian F. Gage is often cited by papers focused on Atrial Fibrillation Management and Outcomes (44 papers), Venous Thromboembolism Diagnosis and Management (43 papers) and Pharmacogenetics and Drug Metabolism (36 papers). Brian F. Gage collaborates with scholars based in United States, Canada and United Kingdom. Brian F. Gage's co-authors include Martha J. Radford, Amy D. Waterman, Michael W. Rich, Michael Boechler, William D. Shannon, Paul E. Milligan, David S. Nilasena, Elena Birman-Deych, Yan Yan and Howard L. McLeod and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Brian F. Gage

174 papers receiving 16.8k citations

Hit Papers

Validation of Clinical Cl... 2001 2026 2009 2017 2001 2005 2006 2001 2009 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Validation of Clinical Classification Schemes for Predicting Stroke
    2001 3.6k citations Brian F. Gage, Amy D. Waterman et al. profile →
  2. Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
    2005 988 citations Brian F. Gage et al. profile →
  3. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    2006 733 citations Brian F. Gage, Paul E. Milligan et al. American Heart Journal profile →
  4. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
    2001 694 citations Randi J. Hagerman, Maureen A. Leehey et al. Neurology profile →
  5. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
    2009 667 citations Sumeet Subherwal, Brian F. Gage et al. Circulation profile →
  6. Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors
    2005 634 citations Amy D. Waterman, David S. Nilasena et al. profile →
  7. Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
    2008 595 citations Brian F. Gage, Elena Deych et al. profile →
  8. Selecting Patients With Atrial Fibrillation for Anticoagulation
    2004 550 citations Brian F. Gage et al. Circulation profile →
  9. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
    2011 473 citations Brian F. Gage et al. profile →
  10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
    2017 435 citations Brian F. Gage et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian F. Gage United States 55 9.7k 4.2k 3.5k 2.2k 1.9k 180 17.4k
Elaine M. Hylek United States 79 24.3k 2.5× 1.3k 0.3× 11.1k 3.1× 4.6k 2.0× 2.2k 1.1× 252 31.2k
Jack Ansell United States 62 11.7k 1.2× 1.4k 0.3× 7.5k 2.1× 1.7k 0.8× 932 0.5× 225 16.4k
Luis A. Garcı́a Rodrı́guez Spain 65 3.8k 0.4× 1.1k 0.3× 577 0.2× 1.6k 0.7× 682 0.4× 282 15.3k
Janice Pogue Canada 42 14.7k 1.5× 294 0.1× 4.7k 1.3× 2.9k 1.3× 1.3k 0.7× 74 19.3k
Jonathan L. Halperin United States 88 29.0k 3.0× 629 0.1× 9.5k 2.7× 6.2k 2.8× 1.6k 0.8× 305 35.1k
Colin Baigent United Kingdom 51 8.9k 0.9× 377 0.1× 1.6k 0.5× 1.8k 0.8× 3.7k 1.9× 136 22.6k
Stephen E. Kimmel United States 55 4.0k 0.4× 1.3k 0.3× 353 0.1× 928 0.4× 817 0.4× 155 10.0k
Harald Darius Germany 43 11.8k 1.2× 256 0.1× 4.5k 1.3× 2.2k 1.0× 1.6k 0.9× 202 17.9k
Rafael Díaz Argentina 45 12.7k 1.3× 208 0.0× 4.1k 1.1× 1.9k 0.9× 1.0k 0.5× 130 18.4k
Michael D. Ezekowitz United States 75 41.4k 4.3× 727 0.2× 13.3k 3.8× 7.7k 3.4× 2.6k 1.3× 269 47.8k

Countries citing papers authored by Brian F. Gage

Since Specialization
Citations

This map shows the geographic impact of Brian F. Gage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian F. Gage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian F. Gage more than expected).

Fields of papers citing papers by Brian F. Gage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian F. Gage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian F. Gage. The network helps show where Brian F. Gage may publish in the future.

Co-authorship network of co-authors of Brian F. Gage

This figure shows the co-authorship network connecting the top 25 collaborators of Brian F. Gage. A scholar is included among the top collaborators of Brian F. Gage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian F. Gage. Brian F. Gage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shiyang, Chongliang Luo, Michelle Doering, et al.. (2025). Catheter and Surgical Ablation for Atrial Fibrillation. Annals of Internal Medicine. 178(8). 1138–1149.
2.
Go, Alan S., Sana M. Al‐Khatib, Patrice Desvigne‐Nickens, et al.. (2023). Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 54(3). 4 indexed citations
3.
Sanfilippo, Kristen M., Yan Yan, Marc Carrier, & Brian F. Gage. (2023). Discriminating Risk of Anticoagulant-Related Bleeding in Ambulatory Cancer Patients on Thromboprophylaxis. Blood. 142(Supplement 1). 567–567. 1 indexed citations
4.
Sanfilippo, Kristen M., Tzu‐Fei Wang, Marc Carrier, et al.. (2022). Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. Journal of Thrombosis and Haemostasis. 20(8). 1920–1927. 4 indexed citations
5.
Dale, Ann Marie, Skye Buckner‐Petty, Bradley Evanoff, & Brian F. Gage. (2020). Predictors of long‐term opioid use and opioid use disorder among construction workers: Analysis of claims data. American Journal of Industrial Medicine. 64(1). 48–57. 15 indexed citations
6.
Giri, Tusar, et al.. (2019). Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis. International Journal for Vitamin and Nutrition Research. 90(1-2). 42–48. 10 indexed citations
7.
Sanfilippo, Kristen M., Suhong Luo, Kenneth R. Carson, & Brian F. Gage. (2017). Aspirin May be Inadequate Thromboprophylaxis in Multiple Myeloma. Blood. 130. 3419–3419. 7 indexed citations
8.
Kaboli, Peter J., et al.. (2016). Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System. American Heart Journal. 179. 186–191. 11 indexed citations
9.
Li, Juan, et al.. (2015). Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation. Journal of General Internal Medicine. 30(6). 777–782. 8 indexed citations
10.
Nägele, Peter, et al.. (2013). Influence of Nitrous Oxide Anesthesia, B-Vitamins, and MTHFR Gene Polymorphisms on Perioperative Cardiac Events. Anesthesiology. 119(1). 19–28. 17 indexed citations
11.
Li, Juan, et al.. (2012). Abstract 13427: Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation. Circulation. 1 indexed citations
12.
Shah, Shimoli & Brian F. Gage. (2011). Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation. Circulation. 123(22). 2562–2570. 251 indexed citations
13.
Harris, Jenine K., Paul M. Ridker, Paul E. Milligan, et al.. (2009). Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. Journal of Thrombosis and Haemostasis. 8(1). 95–100. 61 indexed citations
14.
Lenzini, Petra, Gloria R. Grice, Paul E. Milligan, et al.. (2008). Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients. Journal of Thrombosis and Haemostasis. 6(10). 1655–1662. 66 indexed citations
15.
Grice, Gloria R., et al.. (2008). Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes. Journal of Thrombosis and Haemostasis. 6(9). 1445–1449. 15 indexed citations
16.
Baruch, Lawrence, Brian F. Gage, Jay Horrow, et al.. (2007). Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?. Stroke. 38(9). 2459–2463. 57 indexed citations
17.
Hagerman, Randi J., Maureen A. Leehey, W L Heinrichs, et al.. (2001). Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 57(1). 127–130. 694 indexed citations breakdown →
18.
Gage, Brian F., Amy D. Waterman, William Shannon, et al.. (2001). Validation of Clinical Prediction Rules for Stroke: Results from the National Registry of Atrial Fibrillation (NRAF) Project. Stroke. 32. 323–323. 3 indexed citations
19.
Yusen, Roger D., et al.. (1999). Outpatient Treatment of Deep Venous Thrombosis. CHEST Journal. 116(5). 1493–1493. 1 indexed citations
20.
Gage, Brian F., et al.. (1997). The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.. American Journal of Ophthalmology. 123(1). 152–153. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine M. Hylek Breakdown of academic impact, for papers by Jack Ansell Breakdown of academic impact, for papers by Luis A. Garcı́a Rodrı́guez Breakdown of academic impact, for papers by Janice Pogue Breakdown of academic impact, for papers by Jonathan L. Halperin Breakdown of academic impact, for papers by Colin Baigent Breakdown of academic impact, for papers by Stephen E. Kimmel Breakdown of academic impact, for papers by Harald Darius Breakdown of academic impact, for papers by Rafael Díaz Breakdown of academic impact, for papers by Michael D. Ezekowitz
Rankless by CCL
2026